Lv2
118 积分 2025-02-25 加入
The clinical pathological significance of TLSs in HER2-low breast cancer
8天前
已完结
Predictive value of tumor-infiltrating lymphocytes for neoadjuvant therapy response and prognosis in breast cancer: a multicenter retrospective study based on Chinese population
1个月前
已完结
Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: integrated analysis with the tumor microenvironment and clinicopathological features
1个月前
已完结
Posttreatment MRI to Predict Pathologic Complete Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy
2个月前
已完结
Harnessing Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Opportunities and Barriers to Clinical Integration
3个月前
已完结
Tumor microenvironment and immunotherapy for triple-negative breast cancer
3个月前
已关闭
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
3个月前
已完结
Tumor-Infiltrating Lymphocytes and Prognosis in Stage I-III Triple-Negative Breast Cancer: A Retrospective Analysis of 258 Patients Treated Without Neoadjuvant Therapy
3个月前
已关闭
Associations of NPAR index with breast cancer incidence and mortality based on the National Health and Nutrition Examination Survey (NHANES) 2001-2018: a cross-sectional study
4个月前
已完结
CDK4/6 inhibitors in breast cancer therapy: mechanisms of drug resistance and strategies for treatment
5个月前
已完结
皖公网安备34019202002308
